Showing results (151-160 of 1,648) with videos related to
Sort By:
Pageof 165
Hepatology International|February 26, 2021
Checkpoint inhibitor induced hepatitis and the relation with liver metastasis and outcome in advanced melanoma patientsMaaike Biewenga, Monique K van der Kooij, Michel W J M Wouters, et al.Hepatology International|August 3, 2019
Association between neutrophil-lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinomaYifei Zhang, N Patrik Brodin, Nitin Ohri, et al.Hepatology International|August 22, 2019
The change in the nationwide seroprevalence of hepatitis C virus and the status of linkage to care in South Korea from 2009 to 2015Eun Sun Jang, Moran Ki, Hwa Young Choi, et al.Hepatology International|September 28, 2019
Finite nucleos(t)ide analog therapy in HBeAg-negative chronic hepatitis B: an emerging paradigm shiftYun-Fan LiawHepatology International|September 28, 2019
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosisQianyi Wang, Hong You, Xiaojuan Ou, et al.Hepatology International|September 19, 2019
Clinical and morpho-molecular classifiers for prediction of hepatocellular carcinoma prognosis and recurrence after surgical resectionXiuming Zhang, Yanfeng Bai, Lei Xu, et al.Hepatology International|November 1, 2018
Identifying barriers to treatment of HCV in the primary care settingSteve Johnson, Kristina Aluzaite, Anna Taar, et al.Hepatology International|April 26, 2014
Role of steroid minimization in the tacrolimus-based immunosuppressive regimen for liver transplant recipients: a systematic review and meta-analysis of prospective randomized controlled trialsJinyang Gu, Xingyu Wu, Lei Lu, et al.Hepatology International|March 5, 2021
Combining end-of-treatment HBsAg and baseline hepatitis B core-related antigen reduce HBV relapse rate after tenofovir cessationYuan-Hung Kuo, Jing-Houng Wang, Chao-Hung Hung, et al.Pageof 165